| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-12 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |